Unity Biotechnology, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan

Unity Biotechnology, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $68.00K, a 25.27% decline year-over-year.
• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $91.00K, a 27.20% decline year-over-year.
• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $125.00K, a 36.22% decline year-over-year.
• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2021-06-30 was $196.00K, a 49.09% decline year-over-year.
• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $77.00K, a 33.62% decline from fiscal 2023.
• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $116.00K, a 18.31% decline from fiscal 2022.
• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $142.00K, a 59.08% decline from fiscal 2021.
• Unity Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $347.00K, a 39.76% decline from fiscal 2020.